Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer (original) (raw)

References

1. Courjal, F. et al. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours. Br. J. Cancer 74, 1984–1989 (1996).
   Article CAS PubMed PubMed Central Google Scholar
2. Sonoda, G. et al. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 20, 320–328 (1997).
   Article CAS PubMed Google Scholar
3. Diebold, J. et al. 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization. J. Pathol. 190, 564–571 (2000).
   Article CAS PubMed Google Scholar
4. Lund, A., Knudsen, S.M., Vissing, H., Clark, B. & Tommerup, N. Assignment of human elongation factor 1α genes: EEF1A maps to chromosome 6q14 and EEF1A2 to 20q13. 3. Genomics 36, 359–361 (1996).
   Article CAS PubMed Google Scholar
5. Hershey, J.W. Translational control in mammalian cells. Annu. Rev. Biochem. 60, 717–755 (1991).
   Article CAS PubMed Google Scholar
6. Condeelis, J. Elongation factor 1 α, translation and the cytoskeleton. Trends Biochem. Sci. 20, 169–170 (1995).
   Article CAS PubMed Google Scholar
7. Yang, F., Demma, M., Warren, V., Dharmawardhane, S. & Condeelis, J. Identification of an actin-binding protein from Dictyostelium as elongation factor 1α. Nature 347, 494–496 (1990).
   Article CAS PubMed Google Scholar
8. Shiina, N., Gotoh, Y., Kubomura, N., Iwamatsu, A. & Nishida, E. Microtubule severing by elongation factor 1 α. Science 266, 282–285 (1994).
   Article CAS PubMed Google Scholar
9. Lee, S., Francoeur, A.M., Liu, S. & Wang, E. Tissue-specific expression in mammalian brain, heart, and muscle of S1, a member of the elongation factor-1 α gene family. J. Biol. Chem. 267, 24064–24068 (1992).
   CAS PubMed Google Scholar
10. Knudsen, S.M., Frydenberg, J., Clark, B.F. & Leffers, H. Tissue-dependent variation in the expression of elongation factor-1 α isoforms: isolation and characterisation of a cDNA encoding a novel variant of human elongation-factor 1 α. Eur. J. Biochem. 215, 549–554 (1993).
    Article CAS PubMed Google Scholar
11. Berry, R. et al. Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am. J. Hum. Genet. 67, 82–91 (2000).
    Article CAS PubMed PubMed Central Google Scholar
12. Kjaer, S. et al. Generation and epitope mapping of high-affinity scFv to eukaryotic elongation factor 1A by dual application of phage display. Eur. J. Biochem. 268, 3407–3415 (2001).
    Article CAS PubMed Google Scholar
13. Land, H., Parada, L.F. & Weinberg, R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596–602 (1983).
    Article CAS PubMed Google Scholar
14. Provencher, D.M. et al. Characterization of four novel epithelial ovarian cancer cell lines. In Vitro Cell. Dev. Biol. Anim. 36, 357–361 (2000).
    Article CAS PubMed Google Scholar
15. Collins, C. et al. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc. Natl Acad. Sci. USA 95, 8703–8708 (1998).
    Article CAS PubMed PubMed Central Google Scholar
16. Albertson, D.G. et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nature Genet. 25, 144–146 (2000).
    Article CAS PubMed Google Scholar
17. Bischoff, J.R. et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17, 3052–3065 (1998).
    Article CAS PubMed PubMed Central Google Scholar
18. Nonet, G.H. et al. The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res. 61, 1250–1254 (2001).
    CAS PubMed Google Scholar
19. Walters, M.R. Newly identified actions of the vitamin D endocrine system. Endocr. Rev. 13, 719–764 (1992).
    CAS PubMed Google Scholar
20. Shultz, L.D., Sweet, H.O., Davisson, M.T. & Coman, D.R. 'Wasted', a new mutant of the mouse with abnormalities characteristic to ataxia telangiectasia. Nature 297, 402–404 (1982).
    Article CAS PubMed Google Scholar
21. Chambers, D.M., Peters, J. & Abbott, C.M. The lethal mutation of the mouse wasted (wst) is a deletion that abolishes expression of a tissue-specific isoform of translation elongation factor 1α, encoded by the Eef1a2 gene. Proc. Natl Acad. Sci. USA 95, 4463–4468 (1998).
    Article CAS PubMed PubMed Central Google Scholar
22. Potter, M., Bernstein, A. & Lee, J.M. The wst gene regulates multiple forms of thymocyte apoptosis. Cell. Immunol. 188, 111–117 (1998).
    Article CAS PubMed Google Scholar
23. Kerekatte, V. et al. The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas. Int. J. Cancer 64, 27–31 (1995).
    Article CAS PubMed Google Scholar
24. Anthony, B., Carter, P. & De Benedetti, A. Overexpression of the proto-oncogene/translation factor 4E in breast-carcinoma cell lines. Int. J. Cancer 65, 858–863 (1996).
    Article CAS PubMed Google Scholar
25. Sonenberg, N. Translation factors as effectors of cell growth and tumorigenesis. Curr. Opin. Cell Biol. 5, 955–960 (1993).
    Article CAS PubMed Google Scholar
26. Shen, R., Su, Z.Z., Olsson, C.A. & Fisher, P.B. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc. Natl Acad. Sci. USA 92, 6778–6782 (1995).
    Article CAS PubMed PubMed Central Google Scholar
27. Demetrick, D.J. The use of archival frozen tumor tissue imprint specimens for fluorescence in situ hybridization. Mod. Pathol. 9, 133–136 (1996).
    CAS PubMed Google Scholar

Download references